REXO1
geneOn this page
Also known as EloA-BP1KIAA1138
Summary
REXO1 (RNA exonuclease 1 homolog, HGNC:24616) is a protein-coding gene on chromosome 19p13.3, encoding RNA exonuclease 1 homolog (Q8N1G1). Seems to have no detectable effect on transcription elongation in vitro.
Predicted to enable exonuclease activity. Predicted to be involved in rRNA 3’-end processing. Located in nuclear body.
Source: NCBI Gene 57455 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 284 total
- MANE Select transcript:
NM_020695
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24616 |
| Approved symbol | REXO1 |
| Name | RNA exonuclease 1 homolog |
| Location | 19p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | EloA-BP1, KIAA1138 |
| Ensembl gene | ENSG00000079313 |
| Ensembl biotype | protein_coding |
| OMIM | 609614 |
| Entrez | 57455 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 5 protein_coding, 3 retained_intron, 2 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000170168, ENST00000586291, ENST00000586343, ENST00000587404, ENST00000587524, ENST00000588743, ENST00000590936, ENST00000643515, ENST00000919437, ENST00000919438, ENST00000919439
RefSeq mRNA: 1 — MANE Select: NM_020695
NM_020695
CCDS: CCDS32866
Canonical transcript exons
ENST00000170168 — 16 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000655704 | 1816225 | 1816345 |
| ENSE00000655711 | 1817219 | 1817329 |
| ENSE00000892148 | 1815248 | 1816154 |
| ENSE00000892149 | 1816431 | 1816569 |
| ENSE00001633860 | 1823572 | 1823785 |
| ENSE00001665814 | 1825839 | 1825943 |
| ENSE00001684128 | 1821519 | 1821682 |
| ENSE00001752596 | 1819934 | 1820057 |
| ENSE00002300170 | 1848202 | 1848483 |
| ENSE00002711113 | 1826878 | 1828631 |
| ENSE00003513973 | 1818706 | 1818843 |
| ENSE00003583964 | 1819018 | 1819131 |
| ENSE00003657801 | 1816698 | 1816813 |
| ENSE00003723483 | 1818482 | 1818595 |
| ENSE00003747059 | 1820264 | 1820395 |
| ENSE00003747349 | 1817707 | 1817780 |
Expression profiles
Bgee: expression breadth ubiquitous, 173 present calls, max score 97.78.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.2967 / max 193.3725, expressed in 1757 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 178074 | 7.6518 | 1749 |
| 178075 | 0.6024 | 312 |
| 178070 | 0.0273 | 3 |
| 178069 | 0.0076 | 3 |
| 178068 | 0.0050 | 3 |
| 178071 | 0.0025 | 2 |
Top tissues by expression
228 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 97.78 | gold quality |
| left testis | UBERON:0004533 | 97.63 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 95.64 | gold quality |
| right adrenal gland | UBERON:0001233 | 95.35 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 94.84 | gold quality |
| left adrenal gland | UBERON:0001234 | 94.80 | gold quality |
| testis | UBERON:0000473 | 94.04 | gold quality |
| adrenal cortex | UBERON:0001235 | 93.36 | gold quality |
| spleen | UBERON:0002106 | 93.19 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 93.08 | gold quality |
| skin of leg | UBERON:0001511 | 92.81 | gold quality |
| sural nerve | UBERON:0015488 | 92.58 | gold quality |
| granulocyte | CL:0000094 | 92.47 | gold quality |
| adrenal gland | UBERON:0002369 | 92.36 | gold quality |
| right frontal lobe | UBERON:0002810 | 92.33 | gold quality |
| skin of abdomen | UBERON:0001416 | 92.24 | gold quality |
| apex of heart | UBERON:0002098 | 91.77 | gold quality |
| right lobe of liver | UBERON:0001114 | 91.71 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 91.47 | gold quality |
| transverse colon | UBERON:0001157 | 91.45 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 91.38 | gold quality |
| left uterine tube | UBERON:0001303 | 91.22 | gold quality |
| right lung | UBERON:0002167 | 91.13 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 91.03 | gold quality |
| putamen | UBERON:0001874 | 90.90 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 90.77 | gold quality |
| right ovary | UBERON:0002118 | 90.70 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 90.64 | gold quality |
| left ovary | UBERON:0002119 | 90.51 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 90.51 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.98 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
43 targeting REXO1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-32-5P | 99.98 | 75.21 | 1964 |
| HSA-MIR-92A-3P | 99.98 | 75.21 | 1960 |
| HSA-MIR-92B-3P | 99.98 | 75.25 | 1955 |
| HSA-MIR-25-3P | 99.98 | 74.60 | 1817 |
| HSA-MIR-363-3P | 99.98 | 74.72 | 1821 |
| HSA-MIR-367-3P | 99.98 | 74.83 | 1819 |
| HSA-MIR-185-3P | 99.95 | 67.01 | 1743 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-137-3P | 99.87 | 74.74 | 2401 |
| HSA-MIR-6756-5P | 99.82 | 67.97 | 2466 |
| HSA-MIR-6739-5P | 99.80 | 67.87 | 2806 |
| HSA-MIR-6733-5P | 99.74 | 67.94 | 2759 |
| HSA-MIR-6752-3P | 99.72 | 66.71 | 1587 |
| HSA-MIR-6766-5P | 99.68 | 67.70 | 2325 |
| HSA-MIR-7-5P | 99.67 | 70.53 | 1809 |
| HSA-MIR-762 | 99.58 | 66.61 | 1994 |
| HSA-MIR-3153 | 99.55 | 67.59 | 2337 |
| HSA-MIR-4489 | 99.50 | 65.56 | 785 |
| HSA-MIR-4498 | 99.47 | 67.42 | 2360 |
| HSA-MIR-6722-3P | 99.45 | 67.62 | 1919 |
| HSA-MIR-4505 | 99.27 | 67.81 | 2678 |
| HSA-MIR-5787 | 99.22 | 67.86 | 2628 |
| HSA-MIR-4291 | 99.20 | 68.88 | 2969 |
| HSA-MIR-328-5P | 99.08 | 64.65 | 1000 |
| HSA-MIR-371A-5P | 99.08 | 66.51 | 1914 |
| HSA-MIR-5001-5P | 99.05 | 66.76 | 1972 |
Literature-anchored findings (GeneRIF, showing 3)
- cloning and characterization of a novel human exonuclease domain-containing protein, Elongin A-binding protein 1; it is capable of binding not only the NH(2)-terminal approximately 120 amino acid region of Elongin A, but also that of SII (PMID:12943681)
- These findings showed that REX1 regulates the proliferation/differentiation of human mesenchymal stem cells through the suppression of p38 MAPK signaling via the direct suppression of MKK3. (PMID:20463961)
- Loss of REX1 expression demarcates stable, OCT4-positive lineage pluripotent human embryonic stem cells. (PMID:23437358)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Rexo1 | ENSMUSG00000047417 |
| rattus_norvegicus | Rexo1 | ENSRNOG00000017916 |
Paralogs (5): REXO5 (ENSG00000005189), ISG20L2 (ENSG00000143319), REXO4 (ENSG00000148300), ISG20 (ENSG00000172183), AEN (ENSG00000181026)
Protein
Protein identifiers
RNA exonuclease 1 homolog — Q8N1G1 (reviewed: Q8N1G1)
Alternative names: Elongin-A-binding protein 1, Transcription elongation factor B polypeptide 3-binding protein 1
All UniProt accessions (4): Q8N1G1, A0A087WY50, A0A2R8Y7I5, K7ESH4
UniProt curated annotations — full annotation on UniProt →
Function. Seems to have no detectable effect on transcription elongation in vitro.
Subunit / interactions. Interacts with TCEA2 and ELOA.
Subcellular location. Nucleus.
Tissue specificity. Ubiquitously expressed.
Similarity. Belongs to the REXO1/REXO3 family.
RefSeq proteins (1): NP_065746* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR012337 | RNaseH-like_sf | Homologous_superfamily |
| IPR013520 | Ribonucl_H | Domain |
| IPR031736 | REXO1-like_dom | Domain |
| IPR034922 | REX1-like_exo | Domain |
| IPR036397 | RNaseH_sf | Homologous_superfamily |
| IPR047021 | REXO1/3/4-like | Family |
Pfam: PF15870
UniProt features (28 total): modified residue 9, compositionally biased region 6, region of interest 5, sequence variant 4, chain 1, domain 1, sequence conflict 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N1G1-F1 | 59.13 | 0.20 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (9): 191, 287, 289, 358, 459, 499, 526, 610, 914
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 106 (showing top):
GOBP_RIBOSOME_BIOGENESIS, GOMF_NUCLEASE_ACTIVITY, YY1_Q6, YY1_02, GOBP_RRNA_3_END_PROCESSING, CONRAD_STEM_CELL, GOMF_EXONUCLEASE_ACTIVITY, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS, GATGKMRGCG_UNKNOWN, GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN, GCCATNTTG_YY1_Q6, GOCC_NUCLEAR_BODY, chr19p13, AAGWWRNYGGC_UNKNOWN, GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ESTER_BONDS
GO Biological Process (1): rRNA 3’-end processing (GO:0031125)
GO Molecular Function (4): nucleic acid binding (GO:0003676), exonuclease activity (GO:0004527), nuclease activity (GO:0004518), hydrolase activity (GO:0016787)
GO Cellular Component (3): nucleus (GO:0005634), nucleoplasm (GO:0005654), nuclear body (GO:0016604)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| rRNA processing | 1 |
| RNA 3’-end processing | 1 |
| binding | 1 |
| nuclease activity | 1 |
| hydrolase activity, acting on ester bonds | 1 |
| catalytic activity, acting on a nucleic acid | 1 |
| catalytic activity | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
| nucleoplasm | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
1568 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| REXO1 | ELOA | Q14241 | 918 |
| REXO1 | TCEA1 | P23193 | 739 |
| REXO1 | ELOA2 | Q8IYF1 | 693 |
| REXO1 | POLR2A | P24928 | 553 |
| REXO1 | EML3 | Q32P44 | 430 |
| REXO1 | REXO2 | Q9Y3B8 | 426 |
| REXO1 | DDX51 | Q8N8A6 | 409 |
| REXO1 | SCAMP4 | Q969E2 | 401 |
| REXO1 | SKIC8 | Q9GZS3 | 401 |
| REXO1 | ZNF276 | Q8N554 | 400 |
| REXO1 | C19orf25 | Q9UFG5 | 396 |
| REXO1 | DUS3L | Q96G46 | 384 |
| REXO1 | LEO1 | Q8WVC0 | 383 |
| REXO1 | VPS9D1 | Q9Y2B5 | 379 |
| REXO1 | PPIE | Q9UNP9 | 371 |
IntAct
10 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| REXO1 | H3-4 | psi-mi:“MI:0915”(physical association) | 0.400 |
| REXO1 | UBA52 | psi-mi:“MI:0915”(physical association) | 0.400 |
| DGCR6 | REXO1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| Rprd1b | POLR2B | psi-mi:“MI:0914”(association) | 0.350 |
| AP2M1 | C1orf226 | psi-mi:“MI:0914”(association) | 0.350 |
| SSRP1 | DDX39A | psi-mi:“MI:0914”(association) | 0.350 |
| SMNDC1 | SMCHD1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| PAFAH1B2 | REXO1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (22): REXO1 (Affinity Capture-MS), TCEB3 (Affinity Capture-Western), TCEB3 (Reconstituted Complex), REXO1 (Two-hybrid), REXO1 (Affinity Capture-MS), REXO1 (Affinity Capture-MS), REXO1 (Affinity Capture-MS), REXO1 (Affinity Capture-MS), REXO1 (Two-hybrid), REXO1 (Proximity Label-MS), REXO1 (Proximity Label-MS), REXO1 (Affinity Capture-MS), REXO1 (Affinity Capture-MS), REXO1 (Affinity Capture-MS), REXO1 (Affinity Capture-MS)
ESM2 similar proteins: A2A7S8, A5D7K1, A5PK23, B1AXH1, F1QGH6, O94885, O95402, Q08495, Q08DM1, Q3T044, Q499V8, Q5HYW2, Q5PQP4, Q5R4B6, Q5R8Q8, Q5SYE7, Q5T0Z8, Q5U2R6, Q6PDH0, Q6PFX7, Q6PGN9, Q6ZVC0, Q7TT28, Q80U35, Q80VC9, Q80Z38, Q86UU1, Q86WR7, Q8BI29, Q8C5R2, Q8CAF4, Q8JZX9, Q8K4J6, Q8N1G1, Q8TF72, Q91Z58, Q969V6, Q96A73, Q9BW04, Q9D0P7
Diamond homologs: A1A5R7, A1Z7K9, A3KPE8, A3LRV8, A4RF51, A5DAD0, A5E1W0, B2GUW6, G0SAK8, O94375, O94443, P0C581, P0CQ08, P0CQ09, P0CQ44, P0CQ45, P48778, P53010, P53015, P53331, Q08237, Q09798, Q0CJU7, Q10124, Q2GSV2, Q2T9U5, Q2YDK1, Q3U1G5, Q4PER6, Q4R9F7, Q4WYA1, Q504Q3, Q54U94, Q5AL29, Q5APK0, Q5B367, Q5F450, Q5REE2, Q6AXU3, Q6C462
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
284 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 243 |
| Likely benign | 17 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3516 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:1816453:T:A | donor_gain | 1.0000 |
| 19:1816694:ACAC:A | donor_loss | 1.0000 |
| 19:1816697:C:CG | donor_loss | 1.0000 |
| 19:1816809:TAGGA:T | acceptor_gain | 1.0000 |
| 19:1816810:AGGA:A | acceptor_gain | 1.0000 |
| 19:1816811:GGA:G | acceptor_gain | 1.0000 |
| 19:1816812:GA:G | acceptor_gain | 1.0000 |
| 19:1816814:C:CC | acceptor_gain | 1.0000 |
| 19:1816814:CTGC:C | acceptor_loss | 1.0000 |
| 19:1816815:T:G | acceptor_loss | 1.0000 |
| 19:1816817:C:CT | acceptor_gain | 1.0000 |
| 19:1816818:G:T | acceptor_gain | 1.0000 |
| 19:1817214:CTCA:C | donor_loss | 1.0000 |
| 19:1817215:TCACC:T | donor_loss | 1.0000 |
| 19:1817216:CACC:C | donor_loss | 1.0000 |
| 19:1817217:A:AC | donor_gain | 1.0000 |
| 19:1817217:A:T | donor_loss | 1.0000 |
| 19:1817218:C:CC | donor_gain | 1.0000 |
| 19:1817218:C:CG | donor_loss | 1.0000 |
| 19:1817218:CCAT:C | donor_gain | 1.0000 |
| 19:1817325:TGTTG:T | acceptor_gain | 1.0000 |
| 19:1817326:GTTG:G | acceptor_gain | 1.0000 |
| 19:1817327:T:C | acceptor_gain | 1.0000 |
| 19:1817327:TTG:T | acceptor_gain | 1.0000 |
| 19:1817328:TG:T | acceptor_gain | 1.0000 |
| 19:1817330:C:CA | acceptor_loss | 1.0000 |
| 19:1817330:C:CC | acceptor_gain | 1.0000 |
| 19:1817336:G:C | acceptor_gain | 1.0000 |
| 19:1817336:G:GC | acceptor_gain | 1.0000 |
| 19:1817702:CTCA:C | donor_loss | 1.0000 |
AlphaMissense
7855 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:1816109:A:G | L1208P | 1.000 |
| 19:1816109:A:T | L1208Q | 1.000 |
| 19:1816117:G:C | C1205W | 1.000 |
| 19:1816118:C:T | C1205Y | 1.000 |
| 19:1816263:A:G | L1180P | 1.000 |
| 19:1816308:A:G | F1165S | 1.000 |
| 19:1816324:C:G | D1160H | 1.000 |
| 19:1816444:A:G | L1148P | 1.000 |
| 19:1816463:G:C | H1142D | 1.000 |
| 19:1816465:C:A | G1141V | 1.000 |
| 19:1816465:C:T | G1141E | 1.000 |
| 19:1816466:C:G | G1141R | 1.000 |
| 19:1816466:C:T | G1141R | 1.000 |
| 19:1816471:A:T | L1139H | 1.000 |
| 19:1816566:A:C | F1107L | 1.000 |
| 19:1816566:A:T | F1107L | 1.000 |
| 19:1816568:A:G | F1107L | 1.000 |
| 19:1817225:G:C | C1065W | 1.000 |
| 19:1819993:G:T | A864D | 1.000 |
| 19:1820325:A:G | L822P | 1.000 |
| 19:1820338:G:T | R818S | 1.000 |
| 19:1816119:A:G | C1205R | 0.999 |
| 19:1816127:G:T | A1202D | 0.999 |
| 19:1816128:C:G | A1202P | 0.999 |
| 19:1816129:G:C | D1201E | 0.999 |
| 19:1816129:G:T | D1201E | 0.999 |
| 19:1816130:T:C | D1201G | 0.999 |
| 19:1816130:T:G | D1201A | 0.999 |
| 19:1816131:C:G | D1201H | 0.999 |
| 19:1816139:G:A | S1198F | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000110872 (19:1843433 G>A,C,T), RS1000140903 (19:1850149 T>C), RS1000372648 (19:1829621 C>A,T), RS1000417486 (19:1849884 G>A,T), RS1000444525 (19:1838163 T>A), RS1000507651 (19:1841724 C>A,T), RS1000537001 (19:1841494 G>A), RS1000540379 (19:1841337 C>G,T), RS1000609783 (19:1820176 T>C,G), RS1000655468 (19:1818330 GC>G), RS1000722711 (19:1837295 C>A), RS1000777255 (19:1841307 C>T), RS1000807287 (19:1845309 C>T), RS1000843656 (19:1832793 G>A), RS1000946179 (19:1832515 C>G,T)
Disease associations
OMIM: gene MIM:609614 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008129_31 | Body mass index | 2.000000e-11 |
| GCST010774_10 | Essential hypertension (time to event) | 4.000000e-08 |
| GCST90002396_6 | Mean reticulocyte volume | 1.000000e-18 |
| GCST90002397_396 | Mean spheric corpuscular volume | 7.000000e-24 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0004918 | age at diagnosis |
| EFO:0010701 | mean reticulocyte volume |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| FR900359 | increases phosphorylation | 1 |
| dicrotophos | increases expression | 1 |
| bufotalin | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| cupric chloride | increases expression | 1 |
| beta-methylcholine | affects expression | 1 |
| fipronil | decreases expression | 1 |
| abrine | increases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Atrazine | increases expression | 1 |
| Caffeine | increases phosphorylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Smoke | decreases expression | 1 |
| Dronabinol | increases expression | 1 |
| Thiram | increases expression | 1 |
| Urethane | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
| p-Chloromercuribenzoic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): essential hypertension